Does AI spell the end for HEOR?

That is the title of my column for my latest column forThe Evidence Base. In this latest edition of Perspectives from the Healthcare Economist, Jason Shafrin (FTI Consulting and Mann School of Pharmacy, University of Southern California) examines how AI is beginning to reshape health economics and outcomes research (HEOR), from evidence generation and literature reviews to…

Read More

ISPOR 2026

Excited to be attending ISPOR 2026 next week. I’m looking for some great plenary sessions, presenting my research on “The Extent of Treatment Response and Preference Heterogeneity in Major Depressive Disorder: Implications for Population-Level Resource Allocation” with co-authors Nadine Zawadzki and Cheryl Neslusan, and meeting up with old colleagues. See you in Philadelphia!

Read More

How will Europe’s economies compare to the US by 2030?

That is the question Luis Garicano asks in his recent post. He relies on projections from the 2025 IMF World Economic Outlook. On the positive side, Eastern European countries’ economies are likely to converge with the US. While we have spent a decade complaining about Europe’s stagnation, a real positive convergence story has been unfolding…

Read More